Prahlad Singh, PhD
President and Chief Executive Officer
With more than 25 years of leadership experience working for global healthcare companies, Prahlad is professionally and personally motivated by the opportunity to make a positive impact on the world. Under his leadership, Revvity’s 11,000 employees deliver best-in-class solutions and service to a diverse range of organizations - advancing science that expands human health and improves lives worldwide.
Before his current role, Prahlad served as President and CEO of PerkinElmer, a position he was appointed to in 2019. During his time in this role, Prahlad led the company through a period of significant transformation - stewarding the organization through the COVID-19 pandemic and overseeing its dramatic portfolio evolution. He was also at the helm when the company completed the divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital, which resulted in the creation of Revvity. Prior to joining PerkinElmer in 2014, Prahlad was General Manager of GE Healthcare’s Women’s Health business. He has also held senior executive level roles in strategy, business development and mergers and acquisitions at both GE Healthcare and Philips Healthcare. Born and raised in India, Prahlad holds a bachelor’s degree in chemistry from the University of Bombay. He moved to the United States to continue his academic career at the University of Missouri-Columbia, where he earned a PhD in chemistry. Prahlad also holds an MBA from Northeastern University’s D’Amore-McKim School of Business. Prahlad currently serves on the Board of Directors of Amphenol Corporation and the Analytical, Life Science & Diagnostics Association (ALDA). Additionally, he is a member of the Massachusetts General Hospital President's Council and an honoree of the Ascend Foundation’s 2023 A-List Awards recognizing outstanding Pan-Asian leaders.
Senior Vice President, Diagnostics
Yves Dubaquie is SVP of Diagnostics at Revvity, responsible for developing and executing the Company’s long-term strategy for its broad specialty diagnostics portfolio, which includes solutions that span immunodiagnostics, infectious disease testing, reproductive health and genomics.
Yves is an accomplished executive with over 20 years of broad healthcare industry experience. He is fascinated by technology and the process of deploying science to positively impact human health. Believing that diagnostics and therapeutics should work in concert to improve patient outcomes, Yves brings deep technical expertise and a collaborative mindset to his work. He encourages his team to leverage their unique skills, capabilities and experiences to work toward common goals and create value for the scientists, innovators and clinicians leveraging Revvity diagnostics solutions.
Prior to Revvity, Yves served three years as SVP of Diagnostics Solutions at MilliporeSigma, the Life Science business of Merck KGaA. Over the course of his career, he has also held various senior leadership and business development roles at Bristol-Myers Squibb, Novartis Molecular Diagnostics and GE Healthcare, among other companies.
Raised in Switzerland, Yves earned a PhD in biochemistry from the University of Basel and a master’s degree in natural sciences from ETH Zurich.
Senior Vice President, Life Sciences
Dr. Alan Fletcher is the SVP of Life Sciences at Revvity. As both a scientist and a strategic business leader, Alan leads a team responsible for shaping the company’s Life Sciences portfolio and delivering solutions that accelerate breakthrough discoveries across therapeutic areas.
Believing that a unified vision and strategy can help solve the world’s greatest health challenges, Alan is a driven and supportive leader who has been instrumental in realizing the company’s R&D vision – transforming innovation from target to cure. Under his leadership, the Life Sciences business has launched numerous market-leading and first-in-class products for existing and emerging areas of science and disease. Alan is a proponent of democratizing technologies for the advancement of new and novel treatments, such as cell and gene therapies, and leads an initiative at Revvity that provides incubator labs and biotech startups with state-of-the-art equipment and resources to fuel their innovation.
Since joining the company in 2008, Alan has held a variety of progressive leadership positions within the Life Sciences business. During this time, he spent one year living and working in China as VP and GM of Sales & Service for the Asia-Pacific region – an opportunity and period of time in his career that he remembers fondly. With more than 30 years of overall experience in the life sciences industry, Alan has also held leadership positions at GE Healthcare Life Sciences as well as Merck & Co. in the United Kingdom.
Born and raised in Wales, Alan earned his PhD in biochemical pharmacology from the University of London, and a bachelor’s degree in biochemistry from Surrey University in the UK. He has been published in more than 30 peer-reviewed publications and served seven years in leadership positions of the Society for Laboratory Automation and Screening (SLAS) and its predecessor the Society of BioMolecular Sciences (SBS).
Senior Vice President, Chief People and Culture Officer
Magali Four is SVP and Chief People and Culture Officer of Revvity. She is responsible for setting the company’s strategic HR agenda and works in close partnership with company leaders to foster an inclusive culture that empowers 11,000 employees to thrive.
Magali is an action-oriented and empathetic leader who champions the company’s values – particularly a passion for people. Believing that engaged employees who are cared for as human beings are an organization’s greatest strength, she is committed to developing and nurturing talent within Revvity as well as continuously enriching company culture. Magali leads an ambitious and purpose-driven team of HR professionals that spans 15+ countries to support Revvity employees worldwide. She plays a leading role in their efforts to build high-performing teams, attract top talent and create positive experiences for employees across the organization.
Before being appointed to her current role in February 2021, Magali served in various HR leadership roles at companies including Intel, GE Healthcare in the Women’s Health segment and at GE Real Estate.
Magali is a graduate of the NEOMA Business School in France. She also holds a European HR Management Certificate from the Institut de Gestion Sociale in Paris.
Senior Vice President, Administration, General Counsel and Secretary
Joel Goldberg is SVP, Administration, General Counsel and Secretary of Revvity – a role in which he applies expert insights and strategic thinking to a variety of legal, regulatory and policy issues affecting the Company.
As a core member of Revvity’s senior leadership team, Joel leads dedicated and solutions-driven teams that work collaboratively and across the business to provide support and guidance on a range of matters and other corporate issues. By encouraging creative thinking and problem-solving, Joel strives to foster an open and honest culture that enables Revvity employees to do their best work on behalf of the business and the organizations it serves.
Prior to joining the Company in July 2008, Joel spent seven years at Millennium Pharmaceuticals, Inc., where he most recently served as VP, Chief Compliance Officer and Secretary. During his time in that role, Joel focused in the areas of mergers and acquisitions, securities and healthcare related compliance and employment law. Before that, Joel was an associate of the law firm Edwards & Angell, LLP (now part of Locke Lord LLP).
Joel is a Boston native and graduate of the Northeastern University School of Law. He completed his undergraduate studies at the University of Wisconsin-Madison and also holds an MBA from Northeastern University.
Madhuri Hegde, PhD
Senior Vice President, Chief Scientific Officer, Global Laboratory Services
Dr. Madhuri Hegde, FACMG, is the SVP and Chief Scientific Officer of Global Laboratory Services at Revvity. She is a medical geneticist, a board-certified diplomat in clinical molecular genetics and the head of Revvity Omics – the Company’s global network of laboratories offering omics services.
Madhuri leads a global team working to provide families and healthcare partners with access to innovative multiomic derived diagnostic technologies with rapid and high-quality results in 155+ countries. Exposed to science and the field of genetics at an early age, her pursuit of a career in this field was heavily influenced by academics and other scientists in her family. Madhuri is a passionate and perpetually curious leader whose team is committed to delivering cutting-edge products to Revvity customers, while keeping a close eye on innovation and bringing those developments to market. Madhuri is energized by bringing people and teams together to make a difference and harness science to positively impact human health.
Making the switch from academia to industry in 2016, Madhuri joined the Company from Emory University in Atlanta, where she served as Executive Director of the Emory Genetics Laboratory and as a professor of human genetics and pediatrics. Before that, she spent several years at the Baylor College of Medicine where she was faculty in the Department of Human Genetics and Director at Baylor Medical Laboratories. She also served several years as a laboratory director at Auckland City Hospital in New Zealand.
Madhuri currently serves on the board and is officer at the American Board of Genetics and Genomics Foundation (ACMGF) and leads ACMG’s International Outreach and Engagement Taskforce. She is also a member of the American Board of Medical Genetics and Genomics (ABMGG) Board of Directors, serves on the Scientific Advisory Board of Coriell Cell Repositories and co-chairs the ClinGen PTEN and is member of the NHGRI ClinGen Cancer Domain Workgroup. She is an adjunct professor of Pediatrics at Emory University School of Medicine and at Georgia Institute of Technology; has either authored or co-authored over 150 peer-reviewed publications and eight book chapters; and presented well over 100 keynote and other invited presentations at major national and international conferences.
Born and raised in India, Madhuri earned her bachelor’s and master’s degrees in microbiology at the University of Mumbai, and a PhD in applied biology and genetics from the University of Auckland. She completed her postdoctoral studies and ABMGG certification at Baylor College of Medicine.
Senior Vice President and Chief Financial Officer
Max Krakowiak is SVP and Chief Financial Officer at Revvity, responsible for leading the Company’s global finance organization.
Max is a team player who fosters a strong culture centered on camaraderie, talent development and winning the controllables. He has played an integral role on Revvity’s finance leadership team since 2018. Before being appointed to his current role in August 2022, Max served as VP of Corporate Finance overseeing financial planning and analysis as well as the commercial and business development finance organizations. He has also served as the Company’s chief of staff for finance and focused on driving global finance transformation through people, process and automation.
Prior to joining the Company, Max spent seven years at GE where he most recently served as a member of the executive leadership team in the company’s corporate audit staff. He worked across GE’s global operating segments to oversee teams responsible for corporate strategy, external investigations and investor relations. Max is also a graduate of the GE Financial Management leadership program.
Max holds a bachelor’s degree in finance from Fordham University in New York City. He also spent time as a minor league baseball player in the Seattle Mariners organization.
Yi-Ping Lin, PhD
Senior Vice President, Chief Quality, Regulatory and Clinical Officer
Dr. Yi-Ping Lin is SVP, Chief Quality, Regulatory and Clinical Officer at Revvity. She brings more than 25 years’ experience in the IVD industry to this role and leads the Company’s QRC team in efforts that accelerate business success.
Yi-Ping is an energic and enthusiastic leader who strives to foster a creative, compliant culture. Her wide-ranging experience in research and development, product support, operations and manufacturing are foundational in her day-to-day work leading Revvity’s QRC team. While remaining laser-focused on building QRC excellence to fuel competitive advantage, Yi-Ping encourages her team to think outside-the-box in how to partner with the business in developing and delivering quality human health solutions to market. Yi-Ping is passionate about diversity and inclusion in the workplace and champions efforts that support and advocate for women and people of color in leadership positions.
Before joining Revvtiy, Yi-Ping worked at Cepheid (a Danaher Corporation company) as SVP, Quality Regulatory and Clinical Affairs, where she led a global QRC organization of more than 700 employees. She has also worked in various leadership roles at Beckman Coulter, Abbott, Roche and Johnson & Johnson (J&J). During her tenure at J&J, Yi-Ping was honored with the New Jersey Tribute to Women and Industry (TWIN) Award in recognition of her significant contributions to the organization and achievements in her field.
Yi-Ping earned a PhD in biochemistry from Rutgers University, where she also completed post-graduate work at the Robert Wood Johnson Medical School.
Senior Vice President, Strategy and Business Development
Dan Tereau is SVP of Strategy and Business Development at Revvity – a position he was appointed to in January 2016. He leads a team of collaborative and keenly intelligent strategists who drive global business development initiatives and are united in the Company’s purpose expand the boundaries of human potential through science.
With more than 30 years’ experience in corporate business development and strategic planning, Dan brings a multifaceted skill set to his work at Revvity. He is energized by the opportunity to do something new every day and believes that learning and growing are the essence of life. To Dan, fearless ambition means tackling challenges without knowing what the outcome may be – whether it’s expanding access to prenatal testing in underserved areas or working through the discovery process to bring a new drug to market.
Before joining the company in 2014, Dan served on Novartis’ leadership team as SVP and Global Head of Strategy, Business Development and Licensing for its consumer health division. Over the course of his career, he has held similar roles at GE Healthcare and Thermo Fisher Scientific.
Dan earned a bachelor’s degree in finance from Ferris State University, a JD from Wayne State University and an MBA from Yale University.
Senior Vice President, Global Chief Information Officer
Jayashree Thacker is SVP and Global Chief Information Officer at Revvity overseeing information technology and digital transformation. The impact of her team’s work provides the Company with solutions and services that deliver the agility needed for superior customer experience, sustainable business growth and optimal return on investment, in a compliant environment.
With more than 35 years of broad business and consulting experience, Jayashree is a technically savvy and skilled leader. She leads by example with a fierce dedication to her work, believing that this evokes a similar commitment from her team of more than 180 IT professionals worldwide. Jayashree’s team has led the modernization of Revvity’s infrastructure, security and applications, including ongoing e-commerce transformation. By remaining constantly curious about emerging technologies, Jayashree is continuously looking for new opportunities to transform the organization using technology.
Before being appointed to her current role in February 2020, Jayashree served as the company’s President for India South Asia & Emerging Markets, where she developed and directed strategies to grow the business across multiple geographies. She also spearheaded the build of Revvity’s multi-functional Global Delivery Centre in India. Before that, Jayashree spent more than 12 years in various leadership roles in the life sciences and healthcare verticals of IBM. She has also held various business consulting positions at PricewaterhouseCoopers and Coopers & Lybrand.
Jayashree completed her undergraduate studies in pharmaceutical sciences at the Institute of Chemical Technology (ICT), Mumbai, and in 2017 received its UAA-ICT Distinguished Alumnus Award in the Professionals category. She also completed an MBA at the Indian Institute of Management, Ahmedabad, and an executive development and leadership program at Cornell University’s Samuel Curtis Johnson Graduate School of Management. Jayashree has also served in various faculty roles at some of the largest business schools in Mumbai.
Senior Vice President and Chief Commercial Officer
Miriame Victor is SVP and Chief Commercial Officer at Revvity. She leads a global team responsible for bringing innovative products and solutions to market that solve problems and expand the boundaries of human potential for Revvity’s customers, partners and collaborators across health and science.
Miriame believes that the future of better human health will involve accessible and easy-to-use diagnostics as well as breakthrough solutions across disease pathways. To realize this vision, she and her team work cross-functionally with Revvity business leaders, product management, R&D professionals and others to deliver complete workflows from discovery to development, and diagnosis to cure. She brings more than 20 years’ experience working in the pharmaceutical, medical device and diagnostics industries to this role and is inspired by embracing the impossible to improve lives everywhere.
Since joining the company in 2014, Miriame has held a number of progressive leadership positions – most recently serving as VP and General Manager of the EMEAI region. She has also worked in various commercial leadership roles at GE Healthcare, Novartis and Merck. She is a graduate of the Experienced Commercial Leadership Program at GE and a certified Six Sigma Black Belt.
Born and raised in Egypt, Miriame earned her bachelor’s degree in clinical pharmacy from Cairo University. She also earned an MBA with a concentration in strategic management from the Arab Academy for Science, Technology and Maritime Transport.
Senior Vice President, Chief Technology Officer
Gintas Vildzius is SVP and Chief Technology Officer at Revvity. He leads the company’s global technology organization focused on advancing core and emerging capabilities across Revvity’s Life Sciences & Diagnostics portfolio – ultimately helping to accelerate innovative, customer-focused solutions in new and existing areas of science and disease.
Gintas started with the company in 2015 and has over 30 years of research & development and global leadership experience. He joined energized by the opportunity to harness science and technology in ways that expand human health for the nearly eight billion people worldwide. Since 2015, he has held a number of progressive leadership positions within Revvity’s R&D organization, most recently as SVP of R&D, driving dozens of new products to market. As both a collaborative and supportive leader, Gintas believes in offering his team the flexibility needed to problem-solve and push past barriers limiting creativity and innovation. Gintas dedicates time to giving back, including the company’s annual volunteer event, its Women’s and Veterans Employee Resource Groups and non-profit organizations including Habitat for Humanity and Food for Free. He has also supported STEM initiatives, including being a science fair judge and giving technology talks to middle school students.
Prior to joining Revvity, Gintas held various global leadership positions over the course of 26 years at GE, living and working in the United States and abroad. Before that, Gintas served four years as a commissioned officer in the United States Air Force. During his service, he was promoted to the rank of Captain and was awarded the U.S. Air Force Commendation Medal.
Gintas holds a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic University in Troy, New York, and a master’s degree in mechanical engineering from Union College in Schenectady, New York. He is also a graduate of the U.S. Air Force ROTC Program and the U.S. Air Force Squadron Officer School.
Senior Vice President, Global Operations
Tajinder Vohra is SVP of Global Operations at Revvity, responsible for overseeing the Company’s manufacturing, supply chain, customer care and distribution functions.
Appointed to his current role in 2015, Tajinder brings nearly 30 years’ experience in operations management to the Revvity team. Originally attracted to this field for its sense of action and urgency, Tajinder leads a global team that collaborates deeply with R&D and Product Management to launch and manufacture products across the Company’s Life Sciences and Diagnostics businesses. His team has reengineered complex fulfillment networks and created digital backbones for eCommerce. He has led technology transfers across multiple countries while managing regulated products and geographically distributed teams.
Prior to his current role, Tajinder ran Operations for ABB in India and its regional supply chain in the Middle East, Africa and India. Before ABB, Tajinder was working in Genpact, a spinoff of GE and a Bain capital company. He helped broaden the service portfolio of the company by incubating and scaling supply chain practices before a successful IPO on the NYSE. Earlier in his career Tajinder worked at GE Healthcare across multiple functions.
Tajinder earned his bachelor’s degree in mechanical engineering from the University of Delhi, a master’s degree in industrial engineering from the University of Alabama and a master’s degree in manufacturing engineering from Lehigh University.
Senior Vice President and General Manager, Revvity Signals Software
Kevin Willoe is SVP and General Manager of Revvity’s Signals Software, which offers a comprehensive suite of enterprise software solutions that enable life-changing breakthroughs across health and science.
Kevin is an entrepreneurial enterprise software executive with more than 25 years’ experience in the IT industry. Under his leadership, the Revvity Signals Software team has a proven track record of meeting or exceeding revenue targets and key business objectives, while enabling customer success in solving critical healthcare issues. Working at the leading edge of today’s continuously evolving technology market, Kevin and his team of more than 800 dynamic, dedicated software professionals are committed to delivering innovative solutions that empower scientists and accelerate research and development.
Before being appointed to his current role, Kevin spent several years in other leadership positions within the company’s Signals business unit, including VP and General Manager and VP of Global Sales. Over the course of his career, Kevin has also worked for Zephyr Health, Spotfire Software (acquired by TIBCO) and MKS Software (acquired by PTC).
Kevin is a graduate of Northeastern University where he earned a bachelor’s degree in business administration.